Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-03-11 Sale |
2024-03-12 9:45 pm |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
18,931 | $0.6698 | $12,680 | 227,210 (Direct) |
View |
2023-03-13 Sale |
2023-03-13 9:20 pm |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
6,648 | $1.53 | $10,171 | 148,141 (Direct) |
View |
2022-09-19 Sale |
2022-09-19 8:28 pm |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
15,642 | $0.7694 | $12,035 | 150,789 (Direct) |
View |
2021-11-12 Purchase |
2021-11-15 6:38 pm |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
20,000 | $1.54 | $30,800 | 20,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-15 Option Award |
2025-04-16 5:12 pm |
N/A 2035-04-15 |
Elicio Therapeutics Inc. | ELTX | Shah Preetam See Remarks |
191,624 | $0 | 191,624 (Direct) |
View |
2024-09-30 Option Award |
2024-10-02 5:19 pm |
N/A 2034-09-29 |
Cidara Therapeutics Inc. | CDTX | Shah Preetam Chief Financial Officer |
130,087 | $0 | 130,087 (Direct) |
View |
2024-03-15 Option Award |
2024-03-20 6:48 pm |
N/A 2034-03-14 |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
326,250 | $0 | 553,460 (Direct) |
View |
2023-03-27 Option Award |
2023-03-29 5:24 pm |
N/A 2033-03-26 |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
270,000 | $0 | 418,141 (Direct) |
View |
2022-09-15 Exercise |
2022-09-19 8:28 pm |
N/A 2022-09-30 |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
50,000 | $0 | 150,789 (Direct) |
View |
2022-03-31 Tax Withholding |
2022-04-04 5:21 pm |
N/A N/A |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
24,820 | $0.83 | 214,931 (Direct) |
View |
2022-03-31 Option Award |
2022-04-04 5:21 pm |
N/A 2032-03-30 |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
219,751 | $0 | 214,931 (Direct) |
View |
2021-09-01 Option Award |
2021-09-03 4:32 pm |
N/A 2031-08-31 |
Cidara Therapeutics Inc. | CDTX | Shah Preetam CFO & CBO |
361,850 | $0 | 361,850 (Direct) |
View |
2020-12-30 Tax Withholding |
2020-12-31 9:20 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Shah Preetam EVP, CFO and Treasurer |
25,000 | $4.64 | 11,600 (Direct) |
View |